Which cancer treatment destroys fewer healthy cells and has a less severe effect on a cancer patient’s health?
The correct answer and explanation is:
The cancer treatment that destroys fewer healthy cells and has a less severe effect on a cancer patient’s health is targeted therapy.
Targeted therapy works by targeting specific molecules involved in the growth and spread of cancer cells. Unlike traditional chemotherapy, which indiscriminately attacks all rapidly dividing cells (including healthy ones), targeted therapy focuses on the genetic mutations or specific proteins that are driving the cancer. By zeroing in on these factors, targeted therapy can block the growth signals of cancer cells, prevent them from dividing, or even help the immune system recognize and destroy cancer cells.
The key advantage of targeted therapy is its precision. It doesn’t affect normal, healthy cells as much as chemotherapy or radiation. Chemotherapy affects both cancerous and healthy fast-growing cells, which leads to many of its well-known side effects, such as hair loss, nausea, and weakness. In contrast, because targeted therapy is designed to interact specifically with the cancer cells’ molecular structures, it is less likely to damage healthy tissues, leading to fewer side effects.
Furthermore, targeted therapies can sometimes be combined with other treatments, including chemotherapy or immunotherapy, to enhance their effectiveness while minimizing adverse effects. Since the treatment is more precise, it generally results in better outcomes with a more manageable side-effect profile compared to traditional cancer treatments.
However, targeted therapy is not suitable for all types of cancer. It’s most effective for cancers that have specific genetic mutations or alterations. Therefore, identifying the molecular basis of the cancer is an essential step before deciding if targeted therapy is an appropriate treatment option. Despite its advantages, there are still challenges, such as resistance developing over time and the high cost of certain targeted treatments.